Mackenzie Financial
TMDX icon

Mackenzie Financial’s Transmedics TMDX Stock Holding History

Mackenzie Financial’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,086
Closed -$254K – 1750
2025
Q4 		$254K Hold
2,086
– – ﹤0.01% 1446
2025
Q3 		$234K Hold
2,086
– – ﹤0.01% 1502
2025
Q2 		$280K Buy
+2,086
New +$229K ﹤0.01% 1425
2025
Q1 		– Sell
-828,147
Closed -$51.6M – 1798
2024
Q4 		$51.6M Buy
828,147
+349,403
+73% +$32.5M 0.07% 218
2024
Q3 		$75.2M Sell
478,744
-128,006
-21% -$19.7M 0.1% 174
2024
Q2 		$91.4M Sell
606,750
-59,536
-9% -$7.14M 0.14% 144
2024
Q1 		$49.3M Buy
666,286
+212,671
+47% +$17.5M 0.07% 223
2023
Q4 		$35.8M Buy
+453,615
New +$27.4M 0.05% 250

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mackenzie Financial's TMDX Position: Q1 2026 in Review

Mackenzie Financial sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 2,086 shares — an estimated $254K sold.

Mackenzie Financial first reported a position in TMDX in Q4 2023 and held it in 8 quarters. The position peaked at $91.4M in Q2 2024. 416 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Mackenzie Financial reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 2,086 Transmedics shares in Q1 2026, an estimated $254K.
  • Mackenzie Financial first reported a position in Transmedics in Q4 2023 and held it in 8 quarters.
  • Mackenzie Financial's Transmedics position peaked at $91.4M in Q2 2024.
  • 416 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.